Mizuho Cuts Surgery Partners (NASDAQ:SGRY) Price Target to $22.00

Surgery Partners (NASDAQ:SGRY) had its price target decreased by Mizuho from $28.00 to $22.00 in a research note published on Monday morning, MarketBeat reports. Mizuho currently has an outperform rating on the stock.

Several other analysts also recently commented on SGRY. JPMorgan Chase & Co. initiated coverage on Surgery Partners in a research note on Thursday, September 18th. They issued a “neutral” rating and a $27.00 target price for the company. Cantor Fitzgerald reiterated an “overweight” rating and issued a $36.00 price target on shares of Surgery Partners in a report on Tuesday, October 7th. Royal Bank Of Canada reduced their price objective on Surgery Partners from $35.00 to $31.00 and set an “outperform” rating for the company in a research note on Tuesday, November 11th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Surgery Partners in a research report on Wednesday, October 8th. Finally, Benchmark cut their target price on Surgery Partners from $35.00 to $30.00 and set a “buy” rating on the stock in a report on Tuesday, November 11th. Seven research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $28.89.

Surgery Partners Stock Up 3.5%

Surgery Partners stock opened at $15.71 on Monday. The company has a quick ratio of 1.78, a current ratio of 1.93 and a debt-to-equity ratio of 1.10. Surgery Partners has a 12-month low of $14.94 and a 12-month high of $26.16. The firm’s fifty day moving average is $20.54 and its 200 day moving average is $21.81. The company has a market capitalization of $2.03 billion, a PE ratio of -10.99 and a beta of 1.85.

Surgery Partners (NASDAQ:SGRY) last posted its quarterly earnings results on Monday, November 10th. The company reported $0.13 EPS for the quarter, missing analysts’ consensus estimates of $0.19 by ($0.06). Surgery Partners had a positive return on equity of 2.51% and a negative net margin of 5.57%.The company had revenue of $821.50 million during the quarter, compared to analyst estimates of $823.55 million. During the same quarter in the previous year, the business posted $0.19 earnings per share. The company’s revenue for the quarter was up 6.6% compared to the same quarter last year. Surgery Partners has set its FY 2025 guidance at EPS. As a group, sell-side analysts predict that Surgery Partners will post 0.67 EPS for the current fiscal year.

Insider Buying and Selling

In other news, insider Harrison R. Bane sold 9,339 shares of the stock in a transaction that occurred on Thursday, September 4th. The stock was sold at an average price of $22.48, for a total value of $209,940.72. Following the completion of the sale, the insider directly owned 117,181 shares of the company’s stock, valued at $2,634,228.88. This represents a 7.38% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 2.70% of the company’s stock.

Institutional Investors Weigh In On Surgery Partners

Several institutional investors have recently bought and sold shares of SGRY. PNC Financial Services Group Inc. raised its position in shares of Surgery Partners by 86.4% in the first quarter. PNC Financial Services Group Inc. now owns 1,169 shares of the company’s stock valued at $28,000 after purchasing an additional 542 shares during the period. AlphaQuest LLC grew its stake in Surgery Partners by 112.0% in the 1st quarter. AlphaQuest LLC now owns 1,058 shares of the company’s stock valued at $25,000 after buying an additional 559 shares in the last quarter. Bank of New York Mellon Corp grew its stake in Surgery Partners by 0.3% in the 1st quarter. Bank of New York Mellon Corp now owns 341,702 shares of the company’s stock valued at $8,115,000 after buying an additional 926 shares in the last quarter. Jones Financial Companies Lllp raised its holdings in Surgery Partners by 313.1% during the 3rd quarter. Jones Financial Companies Lllp now owns 1,227 shares of the company’s stock valued at $27,000 after acquiring an additional 930 shares during the period. Finally, California State Teachers Retirement System lifted its position in shares of Surgery Partners by 1.6% during the second quarter. California State Teachers Retirement System now owns 65,091 shares of the company’s stock worth $1,447,000 after acquiring an additional 1,021 shares in the last quarter.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.